Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RNA45S5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
NGEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF503-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GNPTAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS27L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDLRAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOM1L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THNSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL6ST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM205BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on